Publication | Closed Access

RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis

InflammationNovel Immunomodulatory PeptideMolecular ImmunologyAllergyAutoimmune DiseaseImmunologyClinical SignsPathologyAutoimmunityImmune SystemAutoantibodiesImmunologic DiseaseImmunotherapyMedicineLewis Rat Model